+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2026-2032- Product Image
Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2026-2032- Product Image
Sale

Enzyme-linked Immunosorbent Assay Testing Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4989693
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Enzyme-linked Immunosorbent Assay Testing Market is projected to reach USD 636.82 Million in 2026. It is expected to continue growing at a CAGR of 7.33%, reaching USD 971.88 Million by 2032.

Enzyme-linked immunosorbent assay testing remains a foundational technology for clinical diagnostics, public health surveillance, pharmaceutical research, veterinary health, food safety, and environmental monitoring. ELISA testing is widely used because it can detect and quantify antigens, antibodies, hormones, cytokines, allergens, toxins, and infectious disease markers through established laboratory workflows and adaptable direct, indirect, sandwich, and competitive assay formats.

For diagnostic and reference laboratory leaders, the market is being shaped by demand for high-throughput immunoassay testing, standardized quality systems, and faster clinical decision support. Continued use by public health agencies, regulated laboratories, academic medical centers, and biopharmaceutical research organizations reinforces ELISA as a trusted platform where analytical sensitivity, specificity, reproducibility, traceability, and cost-effective scalability are critical purchasing criteria.

Transformative Shifts in the ELISA Testing Landscape

The ELISA testing landscape is shifting from manual, batch-oriented workflows toward automated, digitally connected, and quality-controlled laboratory operations. Laboratories are increasingly pairing microplate readers, automated washers, liquid handling systems, laboratory information systems, and validated software to reduce variability, improve documentation, and support higher sample volumes across clinical and research settings.

Regulatory expectations are also transforming the market. ISO 15189 accreditation, CLIA requirements in the United States, CLSI guidance, and the European Union In Vitro Diagnostic Regulation emphasize traceability, performance verification, risk management, clinical evidence, and documentation. These forces are making assay validation, lot-to-lot consistency, internal controls, calibration practices, and proficiency testing central to competitive differentiation.

Cumulative Impact of Artificial Intelligence on ELISA Testing

Artificial intelligence is adding cumulative value across the ELISA testing workflow rather than replacing validated immunoassay science. AI-enabled analytics can support plate image review, curve fitting, outlier detection, quality-control trending, reagent inventory planning, sample prioritization, and workload management when integrated with laboratory information systems and governed by validated protocols.

The greatest near-term impact is operational: fewer transcription errors, faster result review, improved flagging of anomalous wells, better longitudinal monitoring of assay performance, and stronger support for corrective and preventive actions. However, laboratories must apply AI within documented quality-management systems, including validation, audit trails, cybersecurity controls, explainability, data integrity, and human oversight to meet clinical and regulatory expectations.

Key Regional Insights for ELISA Testing

North America remains a high-value ELISA testing region because of mature clinical laboratory networks, CLIA-regulated testing, FDA oversight, public health surveillance programs, and strong biomedical research funding. Europe is shaped by IVDR implementation, ISO-aligned quality expectations, and demand for standardized evidence supporting assay performance across clinical diagnostics, research, transfusion safety, allergy testing, autoimmune disease assessment, and infectious disease applications.

Asia-Pacific is expanding through growing diagnostic infrastructure in China, India, Japan, South Korea, and Australia, with demand driven by infectious disease testing, chronic disease monitoring, vaccination programs, food safety, and biopharmaceutical research. Latin America is anchored by Brazil and Mexico, where national regulatory frameworks, reference laboratories, and public health programs influence adoption. The Middle East is investing in advanced healthcare systems, especially in Gulf countries where laboratory modernization and accreditation remain priorities, while Africa continues to prioritize infectious disease surveillance, laboratory network strengthening, donor-supported diagnostics, and accessible immunoassay platforms for decentralized health systems.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets benefit from rising healthcare access, expanding hospital networks, infectious disease monitoring, and regulatory alignment influenced by the ASEAN Medical Device Directive. The GCC is advancing ELISA testing through healthcare modernization, centralized procurement models, national laboratory strategies, and quality-focused diagnostic capacity building aligned with broader health system transformation initiatives.

The European Union is defined by IVDR, making clinical evidence, post-market surveillance, performance evaluation, and manufacturer accountability decisive for ELISA testing adoption. BRICS countries combine large patient populations with expanding local manufacturing, public health needs, and research capacity, supporting demand for scalable immunoassay platforms. G7 countries continue to lead in assay innovation, reference laboratory operations, biomedical funding, and regulatory maturity, while NATO member states also reinforce demand through biosecurity preparedness, infectious disease readiness, military health systems, and resilient diagnostic supply chains.

Key Country Insights for ELISA Testing Adoption

The United States leads through CLIA-certified laboratory capacity, FDA oversight, public health surveillance, academic research, and strong adoption of automated immunoassay workflows, while Canada emphasizes accredited testing, provincial laboratory coordination, and public health laboratory integration. Mexico and Brazil are important Latin American markets supported by hospital expansion, reference laboratories, infectious disease testing needs, and national regulatory agencies that shape diagnostic approvals and quality requirements.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show sustained demand through advanced clinical diagnostics, research networks, autoimmune and allergy testing, and IVDR-adjacent quality expectations, while Russia maintains demand in infectious disease, hospital testing, and regional laboratory services. China and India are expanding access, local production, and high-volume testing capacity; Japan and South Korea emphasize precision, automation, and stringent quality systems; and Australia combines accredited laboratory systems with strong public health surveillance, food safety monitoring, and biomedical research activity.

Actionable Recommendations for ELISA Testing Leaders

Industry leaders should prioritize workflow automation, validated digital connectivity, and quality-management maturity before scaling ELISA testing capacity. Investments in microplate automation, standardized controls, lot verification, proficiency testing, preventive maintenance, staff competency programs, and LIS integration can improve throughput while reducing preventable errors.

Organizations should also build AI governance into laboratory operations, including validation, cybersecurity, audit trails, data integrity controls, documented human review, and change management. Strategic sourcing should emphasize reagent continuity, supplier qualification, cold-chain resilience, alternative supply planning, and regulatory readiness across FDA, IVDR, ISO 15189, CLIA, and CLSI-aligned environments.

Research Methodology for ELISA Testing Intelligence

This executive summary is based on structured secondary research, regulatory review, and market intelligence synthesis across clinical diagnostics, life sciences, public health, food safety, veterinary testing, and laboratory automation. Sources considered include publicly available guidance and frameworks from national and international health authorities, regulatory agencies, standards organizations, accreditation bodies, and peer-reviewed scientific literature.

The methodology emphasizes verified signals rather than unsupported estimates. Regional, group, and country insights were assessed through regulatory direction, laboratory infrastructure, healthcare investment trends, infectious disease surveillance needs, quality-system adoption, public health priorities, and documented adoption patterns for immunoassay automation and laboratory information systems.

Conclusion: ELISA Testing Positioned for Quality-Led Growth

ELISA testing continues to be a resilient, clinically relevant, and commercially important immunoassay platform. Its strength lies in validated science, broad analyte coverage, adaptable formats, established quality controls, and compatibility with automated laboratory workflows.

The next phase of leadership in enzyme-linked immunosorbent assay testing will depend on quality, connectivity, regulatory readiness, supply-chain resilience, and responsible AI adoption. Laboratories and suppliers that combine assay reliability with automation, traceability, and data-driven operations will be best positioned to meet rising needs across diagnostics, research, public health, food safety, veterinary health, and biosecurity applications.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Enzyme-linked Immunosorbent Assay Testing Market, by Product
7.1. Introduction
7.2. Instruments
7.2.1. Microplate Readers
7.2.2. Microplate Washers
7.3. Kits
7.3.1. Automated Kits
7.3.2. Manual Kits
7.4. Reagents
7.4.1. Antibodies
7.4.2. Enzymes
7.4.3. Substrates
7.5. Software And Services
7.5.1. Data Analysis Software
7.5.2. Maintenance Services
8. Enzyme-linked Immunosorbent Assay Testing Market, by Assay Type
8.1. Introduction
8.2. Competitive
8.3. Direct
8.4. Indirect
8.5. Sandwich
9. Enzyme-linked Immunosorbent Assay Testing Market, by Application
9.1. Introduction
9.2. Disease Testing
9.3. Drug Discovery
9.4. Environmental Testing
9.5. Food Safety And Quality
10. Enzyme-linked Immunosorbent Assay Testing Market, by End Users
10.1. Introduction
10.2. Academic And Research
10.3. Contract Research Organizations
10.4. Hospitals And Diagnostics
10.5. Pharmaceutical And Biotech
11. Enzyme-linked Immunosorbent Assay Testing Market, by Distribution Channel
11.1. Introduction
11.2. Online
11.3. Offline
12. Enzyme-linked Immunosorbent Assay Testing Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Enzyme-linked Immunosorbent Assay Testing Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Enzyme-linked Immunosorbent Assay Testing Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Agilent Technologies Inc.
16.3. ANP Technologies, Inc.
16.4. Autobio Diagnostics Co., Ltd.
16.5. Becton, Dickinson and Company
16.6. Bio-Rad Laboratories, Inc.
16.7. Bio-Techne Corporation
16.8. BioLegend, Inc.
16.9. bioMérieux S.A.
16.10. Biosurfit SA
16.11. Boditech Med Inc.
16.12. Charles River Laboratories International, Inc.
16.13. Danaher Corporation
16.14. Epitope Diagnostics Inc.
16.15. F. Hoffmann-La Roche AG
16.16. Fapon Biotech Inc.
16.17. Gyros Protein Technologies AB by Mesa Laboratories, Inc.
16.18. H.U. Group Holdings Inc.
16.19. J. Mitra & Co. Pvt. Ltd.
16.20. Kamiya Biomedical Company
16.21. Merck KGaA
16.22. MiCo BioMed, Inc.
16.23. Nanomix, Inc.
16.24. Promega Corporation
16.25. QIAGEN N.V.
16.26. Quanterix Corporation
16.27. QuidelOrtho Corporation
16.28. Randox Laboratories Ltd.
16.29. Revvity, Inc.
16.30. Shenzhen Micropoint Biotechnologies Co., Ltd.
16.31. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.32. Siemens Healthineers AG
16.33. Sysmex Corporation
16.34. Tecan Trading AG
16.35. Thermo Fisher Scientific Inc.
16.36. Tosoh Corporation
16.37. WAK-Chemie Medical GmbH
16.38. Zoetis Inc.
16.39. Zybio Inc.
List of Figures
FIGURE 1. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL MICROPLATE READERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL MICROPLATE READERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL MICROPLATE READERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MICROPLATE WASHERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MICROPLATE WASHERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MICROPLATE WASHERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL MANUAL KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MANUAL KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MANUAL KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ANTIBODIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ANTIBODIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ANTIBODIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SUBSTRATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL SUBSTRATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL SUBSTRATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SOFTWARE AND SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SOFTWARE AND SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SOFTWARE AND SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DATA ANALYSIS SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL MAINTENANCE SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL COMPETITIVE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL COMPETITIVE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL COMPETITIVE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL DIRECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL DIRECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL DIRECT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INDIRECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INDIRECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL INDIRECT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL SANDWICH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL SANDWICH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SANDWICH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL DISEASE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL DISEASE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL DISEASE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ENVIRONMENTAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL FOOD SAFETY AND QUALITY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL FOOD SAFETY AND QUALITY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL FOOD SAFETY AND QUALITY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL ACADEMIC AND RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL ACADEMIC AND RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ACADEMIC AND RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL HOSPITALS AND DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL HOSPITALS AND DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL HOSPITALS AND DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL AND BIOTECH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL AND BIOTECH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL AND BIOTECH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL ONLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 92. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 102. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 103. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 104. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 105. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 106. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 107. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 108. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 109. NORTH AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 110. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 112. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 113. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 114. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 115. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 116. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 117. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 118. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 119. LATIN AMERICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 120. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 122. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 123. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 124. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 125. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 126. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 127. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 128. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 129. EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 130. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 133. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 134. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 135. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 136. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 137. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 138. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 139. MIDDLE EAST ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 140. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 142. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 143. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 144. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 145. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 146. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 147. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 148. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 149. AFRICA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 152. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 153. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 154. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 155. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 156. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 157. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 158. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 160. ASEAN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 161. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 163. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 164. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 165. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 166. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 167. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 168. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 169. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 170. GCC ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 181. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 182. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 183. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 184. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 185. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 186. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 187. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 188. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 190. BRICS ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 192. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 193. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 194. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 195. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 196. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 197. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 198. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 200. G7 ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 201. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 202. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 203. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 204. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 205. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 206. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 207. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 208. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 209. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 210. NATO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 211. GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 212. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 213. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 214. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 215. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 216. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 217. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 218. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 219. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 220. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 221. UNITED STATES ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 222. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 223. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 224. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 225. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 226. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 227. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 228. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 229. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 230. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 231. CANADA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 232. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 233. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 234. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 235. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 236. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 237. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 238. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 239. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 240. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 241. MEXICO ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 242. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 243. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 244. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 245. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 246. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 247. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 248. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 249. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 251. BRAZIL ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 252. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 253. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 254. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 255. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 256. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 257. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 258. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 259. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 260. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 261. UNITED KINGDOM ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 262. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 263. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 264. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 265. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 266. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 267. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 268. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 269. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 270. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 271. GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 272. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 273. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 274. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 275. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 276. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 277. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 278. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 279. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 281. FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 282. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 283. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 284. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 285. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 286. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 287. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 288. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 289. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 290. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 291. RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 292. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 294. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 295. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 296. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 297. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 298. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 299. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 300. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 301. ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 302. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 303. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 304. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 305. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY KITS, 2017-2032 (USD MILLION)
TABLE 306. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 307. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY SOFTWARE AND SERVICES, 2017-2032 (USD MILLION)
TABLE 308. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY ASSAY TYPE, 2017-2032 (USD MILLION)
TABLE 309. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 310. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY END USERS, 2017-2032 (USD MILLION)
TABLE 311. SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 312. CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 313. CHINA ENZYME-LINKED IMMUNOSORBENT

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • ANP Technologies, Inc.
  • Autobio Diagnostics Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • bioMérieux S.A.
  • Biosurfit SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Danaher Corporation
  • Epitope Diagnostics Inc.
  • F. Hoffmann-La Roche AG
  • Fapon Biotech Inc.
  • Gyros Protein Technologies AB by Mesa Laboratories, Inc.
  • H.U. Group Holdings Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Kamiya Biomedical Company
  • Merck KGaA
  • MiCo BioMed, Inc.
  • Nanōmix, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Quanterix Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Revvity, Inc.
  • Shenzhen Micropoint Biotechnologies Co., Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
  • WAK-Chemie Medical GmbH
  • Zoetis Inc.
  • Zybio Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 636.82 Million
Forecasted Market Value ( USD ) by 2032 $ 971.88 Million
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned39

Related Topics

Related Reports

Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2026-2032 - Product Image

Enzyme-Linked Immunosorbent Assay Service Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report - Product Image

Enzyme-linked Immunosorbent Assay (Elisa) Testing - Global Strategic Business Report

  • Report
  • 262 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Market Report 2026 - Product Image

Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Enzyme-Linked Immunosorbent Assay Testing Market Report 2026 - Product Image

Enzyme-Linked Immunosorbent Assay Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Enzyme Linked Immunosorbent Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Enzyme Linked Immunosorbent Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From

About the Enzyme Linked Immunosorbent Assay Test Market

The Enzyme Linked Immunosorbent Assay (ELISA) Test is a type of In Vitro Diagnostics (IVD) test used to detect and measure the presence of antibodies, antigens, and other proteins in a sample. ELISA tests are used to diagnose a variety of medical conditions, including autoimmune diseases, allergies, and infections. ELISA tests are also used to detect the presence of hormones, toxins, and other substances in the body. The ELISA Test market is a rapidly growing segment of the IVD market. ELISA tests are used in a variety of clinical settings, including hospitals, laboratories, and research facilities. The market is driven by the increasing demand for accurate and reliable diagnostic tests, as well as the development of new technologies and products. Some of the major companies in the ELISA Test market include Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.